New Delhi, Oct 10: The Pharmacopoeial Discussion Group (PDG) announced the Indian Pharmacopoeia Commission (IPC) as a PDG member on October 5, 2023 during PDG Stakeholder’s meeting in Hyderabad. IPC officially joined as a member in the PDG at the PDG’s Annual Meeting which was held on October 3-4, 2023 in Hyderabad. The World Health Organization (WHO) also continues to serve as observer of the PDG.
The PDG, will now bring together the European Pharmacopoeia (Ph. Eur.), the Japanese Pharmacopoeia (JP), the United States Pharmacopeia (USP) and Indian Pharmacopoeia (IP) to harmonize global pharmacopoeial standards. The objective is to reduce manufacturers' burden of having to perform analytical procedures in different ways, using different acceptance criteria, in order to satisfy pharmacopoeial requirements that vary across regions. PDG has defined harmonization of a pharmacopoeial monograph or general chapter as
“A pharmacopoeial general chapter or other pharmacopoeial document is harmonized when a pharmaceutical substance or product tested by the document's harmonized procedure yields the same results and the same accept/reject decision is reached.”